Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

Por Zighelboim, Israel, Wright, Jason D., Gao, Feng, Case, Ashley S., Massad, L. Stewart, Mutch, David G., Powell, Matthew A., Thaker, Premal H., Eisenhauer, Eric L., Cohn, David E., Valea, Fidel A., Secord, Angeles Alvarez, Lippmann, Lynne T., Dehdashti, Farrokh, Rader, Janet S.
Publicado em 2013